T h e W o r k : P rofessional A dvertising Avoid the knockout Waking up alert can be just as important as getting enough sleep. That’s why it’s important that your patients who have difficulty falling asleep start with SONATA*, a nonbenzodiazepine hypnotic without the knockout of next-day cognitive and psychomotor impairment.'* SONATA* provides rapid-onset sleep’ without unnecessary residual effects because it is the only hypnotic of its class with a half-life of approximately 1 hour. SONATA4is irxkated f a the shod-termtreatment of insomnia Alttwugh SONATA* improvedsleep time frcmbaseline in clinic^ trials, it has not been stwwn to increase total time slept or decrease awakenings vs placebo. Hypnotics should generally be limited to 7 to 10 days of use. and reevaluation of patents is recommended if hypnotics are taken for more than 2 to 3 weeks SONATA* prescriptions should not exceed a 1-month supply. Until patients know howthey wit! react tosleep agents, they should not engage in activities requiring mental alertness or motcr coordination (eg. driving cr operating machnety after tatang SONATA* a any sleep agent. In cbnical trials, the most common ssde efforts were headache, dizziness, and somnolence As with any sedative/hypnotic, abrupt treatment discontinuation can produce signs and symptoms cf withdrawal and rebound msorrrsa ’ Psychomotor functions may be impaired for up to 4 hours. Please see Brief Summary of Prescribing Information. (ZALEPLONXS lust Enough! O v e rd o n e N EW SYVEK Introducing New EXCEL the noninvasive Vascular Access Hemostasis System Vascular Access Hemostasis System T\Simply advanced hemostasis 211
RkJQdWJsaXNoZXIy NDMwNDAx